International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). A new collaborative global platform for global clinical trials targeting post-COVID19 patients

Autor: Maria Isabel Cavalcante Siqueira, Miriã Cândida Oliveira, Maria Eduarda Moreira Lino, Shayra Kellen Arantes Souza, Guilherme Augusto Moreira Silva, Renata Silva Rosa Tomaz, Marilúcia De Morais Carrijo, Thays Lisboa Guedes, Beatriz Nascimento Souza, Elisângela Rosa Pereira Póvoa, Rubens Rodrigues Bernardes, Letícia De Souza Galvão, Bianca Mendonça Reis, Raphael Hélvetico Carvalho de Oliveira Diniz, Diogo Marques Paulino, Aline Cândido Oliveira, Rodolfo De Paula Vieira, Vinicius Zacarias Maldaner da Silva, Sara Socorro Faria, Luís Vicente Franco de Oliveira
Rok vydání: 2022
Zdroj: Manual Therapy, Posturology & Rehabilitation Journal. 20:1-6
ISSN: 2236-5435
1677-5937
Popis: Background: In response to the pandemic caused by COVID-19, World Health Organization (WHO), together with International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), developed research protocols facilitating global collaboration and accelerating the understanding of the disease, to identify the potential symptoms and persistent sequelae in infected individuals, which can be used in different areas of health, that is, in primary care, at a hospital or outpatient level, both public and private. Objective: To describe the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) protocol as a new global collaborative platform for global clinical trials targeting post-COVID-19 patients. Methods: The standardized forms were developed from the COVID-19 Clinical Characterization Protocol (PCC) by the ISARIC/WHO working group composed of specialist researchers with experience in clinical research in different areas of medicine and public health, especially outbreaks and infectious diseases. Conclusion: It is expected that the creation of a database composed of different populations from all over the world will help in the characterization of risk factors, in the best form of clinical intervention and in the best prevention strategies for physical, neurological and psychosocial sequelae in the medium and long term in post-COVID-19 patients.
Databáze: OpenAIRE
Externí odkaz: